A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
The hypothalamus houses neurons that produce neuropeptides called orexin A and B, which were discovered in 1998, and represent one of the most exciting discoveries in sleep medicine.5,13–15 Orexin-producing neurons help us stay awake and alert, especially when we really need to focus, which is critical for survival.5,14 These neurons reach out to many brain areas that use other wakefulness messengers such as acetylcholine, dopamine, histamine, serotonin and noradrenaline. These areas ‘talk back’ to the hypothalamus, to further boost wakefulness signals.5 Similarly, the thalamus is an important region that also serves to relay wakefulness signals from the RAS.5
Another dual orexin receptor antagonist (DORA), vornorexant*, is under development and currently undergoing clinical trials.28 
Other medicines such as dimdazenil* (partial positive allosteric modulator at GABAA specific to alpha-1 and alpha-5 GABAA receptor subtypes)41 and zuranolone* (positive allosteric modulator for GABAA) have also been tested, with positive outcomes in trials. Zuranolone* is marketed overseas specifically for postnatal depression, but clinical trials for its use in insomnia are ongoing.40
Kristy Carter (she/her)
Louise Edwards (she/her) 
Spending on medicines rises even as dispensing drops
Australian prescription dispensing volume is lower, but spending on PBS medicines has increased in the past two years, according to the Australian Institute of...
Local knowledge, local supplements
With consumer demand for health supplements increasing, a young established Australian supplier is aiming to better support of healthy lifestyle.
Patients and My Health Record
To opt out or not to opt out: what role does a pharmacist have in helping patients make informed decisions about My Health Record?
The...
How pharmacists can treat people with migraine
A look at the pharmacological and nonpharmacological treatment options and preventative measures that pharmacists can recommend to stave off migraine attacks.
A common reason people...
Pharmacists welcome appointment of new Rural Health Commissioner
Emeritus Professor Paul Worley has been appointed Australia’s first National Rural Health Commissioner, which was welcomed by PSA.
As the new Commissioner, Prof Worley will...
Mental health medicines and drug-related deaths
A recent study of coronial inquest findings revealed medicines relating to mental health conditions (antidepressants, antipsychotics) were most commonly implicated in non-opioid and non-benzodiazepine...
